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Wallace Clark, Jr. was born and raised in La Grange, Georgia, the
son of a much loved and respected country doctor. He was
schooled at The Citadel in Charleston, and at Tulane University in
New Orleans. In 1944 he entered Tulane University School of
Medicine, from which he graduated with an M.D. in 1947. He
trained in Pathology at Tulane University and in the Touro
Infirmary of New Orleans. After two years in the Service, he
became Assistant Professor and later Associate Professor and
Professor (at the age of 36) in the Tulane Department. At Tulane,
Clark developed seminal concepts of pattern pathology applied
especially to dermatopathology that were ultimately to revolu-
tionize the field. He also became expert in the use of a novel
high-tech instrument, the electron microscope, applying it to
the examination of skin and providing original descriptions of
the mela-nocyte, the melanosome, and several basic attributes
of keratinocyte morphology. At Tulane Clark’s thinking about
research and life was profoundly altered by association and
friendship with Emmanuel Farber, now at the University of
Toronto. He also developed a collaboration and deep friendship
with Richard Reed in the study of cutaneous disease. These
Tulane associations have persisted throughout Clark’s life. In the
same period, Clark was a consultant to the Orleans Parish
Coroner’s Office. There are rumors that a certain celebrated
television pathologist was loosely based on the flamboyant New
Orleans coroner’s pathologist of the late 1950 and early 1960
decades. In 1962, Clark was recruited by Thomas Fitz-patrick and
Benjamin Castleman to the Massachusetts General Hospital. In
the stimulating environment of the Departments of Pathology and
of Dermatology at the Harvard Medical School, Clark continued
to develop his concepts of the reaction patterns and morphologic
units of inflammatory disease in the skin. These concepts were
taught to several generations of residents, many of whom later
became influential in the fields of surgical pathology and
dermatopathology. At Harvard also, Clark developed his lifelong
passion for the morphology and biology of the neoplastic diseases
of pigment cells. With Fitzpatrick, he founded the first Pigmented
Lesion Clinic, a model for hundreds of its ilk that now exist world-
wide. In 1974, Clark became Chairman of Pathology at Temple
University School of Medicine in Philadelphia. There he
continued his basic research in melanocytic carcinogenesis,
developed a fine cutaneous electron microscopy unit, established
the first Pigmented Lesion Clinic in Philadelphia, and adminis-
tered a complex department while training residents not only in
diagnostic anatomic pathology but also in his scientific approach
to the study of disease. Several individuals recruited in the
Temple Clinic including Jean Thompson, Marie Synnestvedt, Bill
Witmer, and Isabel Mattozzo were to remain with Clark until his
retirement in 1991, as were many of the patients who were seen
there. In 1978, Clark moved across town to the Dermatology
Department at the University of Pennsylvania, chaired by Walter
Shelley, in a recruitment effected in part by Albert Kligman. An
already extant collaboration with Hilary Koprowski at the Wistar
Institute across the street burgeoned into a program project to
comprehensively study aspects of melanoma cell biology, using
the state of the art technology of the late 1970s, monoclonal
antibodies. Now under the leadership of Meenhard Herlyn, this
collaboration continues into the present molecular era. At Penn,
Clark recruited other collaborators who were to continue as life-
long friends and colleagues, including Dupont Guerry, Ralph
Hamilton, Donato LaRossa, and Edward Bondi and David Elder
(who had moved with him from Temple). To these founding
members of the Pigmented Lesion Group at Penn, Allan Halpern,
Lynn Schuchter, George Murphy, and Rosalie Elenitsas have
been added. In ‘‘retirement’’ since 1991, Clark lives in Maine
but commutes weekly into the Department of Pathology at the
Beth Israel Hospital where he consults, teaches, reads, and
talks about cancer. He also retains an Emeritus Professorship at
the University of Pennsylvania where he continues to contribute
to the Pigmented Lesion Group and the Dermatopathology
Division.
Recently it has become fashionable to acknowledge the term
‘‘physician-scientist’’ as an oxymoron. To the contrary, Wallace
Clark’s approach to the practice of pathology has never
distinguished between the applied and the theoretical. In fact
each serves to fuel the other. Assigning diagnoses is never
employed merely to ‘‘give something a name so as to stop
thinking about it.’’ Rather, diagnostic recognition always stimu-
lates a flood of questions concerning the biologic basis of a
lesion’s cause, evolution, and resolution. Accordingly, what
could have seemed routine becomes the fundamental basis for
scientific exploration, whereas more basic investigations always
are tightly linked to clinically relevant aspects of patient care. As
opposed to the present trend to discourage this approach as
impractical or even impossible, young physician-scientists con-
tinue to be spawned from this paradigm he embodies.
Although Wallace Clark is well recognized as a physician,
scientist, and teacher, those privileged to know him on a personal
level consider him, above all, an intellectual. An intellectual not
only concerns himself with ideas and concepts, but, as Isaiah
Berlin said, ‘‘wants ideas to be as interesting as possible.’’ This is
the strategy that Wallace applies not only to dermatopathology,
but to all his endeavors. He does not just describe or document in
a static manner; rather he tries to enter, view from the ‘‘inside,’’
and in this manner being inert situations to life. Outside the
laboratory, conversations with Wallace reflect his wide scope of
non-scientific, intellectual passions. These discussions, which can
range from how homo sapien could participate in holocausts and
pogroms to the raison d’etre behind the local team’s losing streak
(he never questions winning), are always thought provoking and
stimulating. He is as comfortable arguing the decline of Utopian
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philosophy in the West as he is articulating a concept on the
failure of higher education to educate. Being a serious student of
the human condition and the diversity of cultures, Wallace
constantly strives to understand what motivates people and their
societies. Consequently, he is extremely well versed and learned
in the philosophies underlying the major religions, as well as in
theories of anthropology. Wallace’s pursuits are not solely
cerebral. He is an accomplished photographer (nature and
people), tropical fish fancier, naturalist, bicyclist, California wine
connoisseur, and raconteur as well as a devoted family man.
Wallace Clark’s creativity is measured not only in the
manuscripts listed below in this annotated curriculum vitae, but
also in the institutions that have benefited from his organizational
and motivational skills in the form of productive continuing
research and clinical enterprises. Clark’s formal honors are many:
the Markle Scholarship while at Tulane Medical School; a Gold
Award of the American Academy of Dermatology for electron
microscopy of the ‘‘intercellular bridge’’ and the melanocyte in
1958; and scientific awards and lectureships too many to
enumerate from institutions like the American Cancer Society,
the James Ewing Society of Surgical Oncology, the Academy of
Medicine of Toronto, the College of Physicians of Philadelphia,
and the British Association for Cancer Research, as well as
numerous University Departments and State Societies. Perhaps
one of the most treasured awards was the Wallace H. Clark, Sr.
lectureship in 1980. In 1991, Wallace H. Clark, Jr. was made
Doctor Honors Causa of the ancient University of Liege. The most
long-lived expressions of his contributions, however, will be
preserved in the minds of the many individuals he has influenced,
who will in turn pass along those influences in the continuing
transmission of ideas that characterizes relationships among
mentors, students, collaborators and, indeed, competitors in the
genealogy of science.
SELECTED BIBLIOGRAPHY
Classification of Melanoma Because of Clark’s expertise and
commitment as both a clinician and a pathologist, he was one of
the first to study malignant melanoma using both clinical and
microscopic morphology as a basis to classify the lesions into
stages of development that would ultimately constitute one of the
best-characterized models of tumor progression in humans. The
early studies resulted in three powerful concepts. First, the
progression of melanomas from a plaque stage called the radial
growth phase to a nodule or tumor stage called the vertical
growth phase was clearly described. Second, it was recognized
that variant patterns of radial growth phase could be discerned,
which would later lead to the recognition of differences in
etiology and pathogenesis. Third, the system of ‘‘Clark’s levels) of
invasion was described, constituting the first widely used
prognostic model for melanoma. Clark established a Pigmented
Lesion Clinic that has served as a prototype for others that have
been established world-wide to provide for multi-disciplinary
care of melanoma patients, and to foster study of this important
human cancer.
Clark WH Jr, Mihm MC: Lentigo maligna and lentigo-maligna
melanoma. Am J Pathol 5(l):38–67, 1969
Clark WH Jr, From L, Bernardino EA, Mihm MC: The
histogenesis and biologic behavior of primary human malignant
melanomas of the skin. Cancer Res 29:705–727, 1969
Mihm MC Jr, Clark WH Jr, From L: Current Concepts: the
clinical diagnosis, classification and histogenetic concepts of the
early stages of cutaneous malignant melanoma. N Engl J Med
284:1078–1082, 1971
McGovern VJ, Mihm MC Jr, Bailly C, Booth JC, Clark WH Jr,
Cochran AJ, Hardy EG, Hicks JD, Levene A, Lewis MG, Little JH,
Milton GW: The classification of malignant melanoma and its
histologic reporting. Cancer 32(6):1446–1457, 1973
Clark WH Jr, Ainsworth AM, Bernardino EA, Yang CH, Mihm
MC Jr, Reed RJ: The developmental biology of primary human
malignant melanomas. Semin Oncol 2(2):83–103, 1975
Clark WH Jr, Folberg R, Ainsworth AM: Tumor progression in
primary human cutaneous malignant melanoma. In: Clark WH Jr,
Goldman LI, Mastrangelo MJ (ed). Human Malignant Melanoma.
Grune and Stratton, New York, 1979, pp 15–31
Clark WH Jr, Elder DE, Van Horn M: The biological forms of
malignant melanoma. Hum Pathol 17(5):443–450, 1986
Several papers dealt explicitly with the early diagnosis of
melanoma. Clark’s early observations have by now become
accepted as common wisdom, and have undoubtedly saved
countless lives that might have been lost to advanced melanomas
had not this knowledge become available.
Sober AH, Fitzpatrick TB, Mihm MC, Wise TG, Pearson BJ,
Clark WH Jr, Kopf AW: Early recognition of cutaneous
melanoma. JAMA 242:2795–2799, 1979
Wick MM, Sober AJ, Fitzpatrick TB, Mihm MC, Kopf AW,
Clark WH, Blois MS: Clinical characteristics of early cutaneous
melanoma. Cancer 45(10):2684–2686, 1980
Animal models were used to establish models of tumor
progression analogous to that observed in humans.
Clark WH Jr, Min BH, Kligman LHL: The developmental
biology of induced malignant melanoma in guinea pigs and a
comparison with other neoplastic systems. Cancer Res
36:4079–4091, 1976
Oxenhandler RW, Adelstein RH, Haigh JP, Hook RR Jr, Clark
WH Jr: Malignant melanoma in the Sinclair miniature swine: an
autopsy study of 60 cases. Am J Pathol 96(3):707–720, 1979
Prognostic Models in Melanoma In his early studies of
melanoma, Clark recognized that the lesions could be categor-
ized in terms of their invasion ‘‘level’’ into the skin, and that this
classification correlated with prognosis. The system of ‘‘Clark
levels’’ became universally adopted as the basis of rational
therapy for melanoma, and stimulated investigations that revealed
other factors contributing to survival, such as tumor thickness. At
the same time, a concept was developed of tumor progression
from an early ‘‘radial growth phase’’ that was not associated with
metastatic competence despite the presence of dermal invasion.
Many of these studies, including the latest prognostic model in
which six variables are associated with survival, were developed
using the Pigmented lesion Group database, established and
maintained by Clark, that presently includes clinical, pathologic,
and follow-up data on over 3000 melanoma cases.
Clark WH Jr: A classification of malignant melanoma in man
correlated with histogenesis and biological behavior. In: Ad-
vances in Biology of Skin. Vol VIII: The Pigmentary System.
Pergamon Press, New York, 1967, pp 621-647.
In a study from the first five years of the Pigmented Lesion
Group experience at Penn, the hypothesis that invasive radial
growth phase melanoma does not metastasize was tested.
Elder DE, Guerry D IV, Epstein MN, Zehngebot L, Lusk E, Van
Horn M, Clark WH Jr: Invasive malignant melanomas lacking comp-
etence for metastasis. Am J Dermatopathol 6(suppl 1):55–61, 1984
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The predictive value of invasion levels was tested in several
clinical studies (and was also confirmed in studies by other
investigators).
Goldman LI, Clark WH Jr, Bernardino EA, Ainsworth AM: The
accuracy of predicting lymph node metastases in malignant
melanoma by clinical examination and microstaging. Ann Surg
184(5):537–540, 1976
Suffin SC, Waisman J, Clark WH Jr, Morton DL: Comparison of
the classification by microscopic level of malignant melanoma by
three independent groups of pathologists. Cancer 40:3112–3114,
1977
Holmes EC, Clark WH Jr, Morton DL, Eilber FR, Bochow AJ:
Regional lymph node metastases and the level of invasion of
primary melanomas. Cancer 37:199–201, 1976
In a recent study of cases from the Pigmented Lesion Group
database with eight-year follow-up, the hypothesis that tumor
progression from radial to vertical growth phase is associated
with acquisition of competence for metastasis was confirmed.
Six independent variables associated with survival in vertical
growth phase cases were identified, including lesional thick-
ness, mitotic rate, tumor-infiltrating lymphocytes, presence of
regression, sex of the patient, and location of the lesion on
anatomic subsites.
Clark WH, Elder DE, Guerry DG, Braitman LE, Track BJ,
Schultz MA, Synnestvedt M, Halpern AC: A model predicting
survival in stage I melanoma based upon tumor progression. J
Natl Cancer Inst 81:1893–1904, 1989
Diagnosis and Management of Melanoma Arising out of the
clinical activities in the three pigmented lesion clinics established
by Clark at Harvard, Temple, and Penn, a series of clinical studies
has played a significant role in defining management of
melanoma. The clinical recognition of melanomas in the early
curable radial growth phase was a major theme, as was the
potential role of education in control of mortality from melanoma
by means of early diagnosis
Holmes EC, Moseley HS, Morton DL, Clark WH Jr, Robinson
D, Urist MM: A rational approach to the surgical management of
melanoma. Ann Surg 186(4):481–490, 1977
Cassileth BR, Clark WH Jr, Heiberger RM, March V, Tenaglia
A: Relationship between patients’ early recognition of melanoma
and depth of invasion. Cancer 49:198–200, 1982
Elder DE, Guerry DIV, Heiberger RM, LaRossa D, Goldman LI,
Clark WH Jr, Thompson CJ, Matozzo I, Van Horn M: Optimal
resection margin for cutaneous malignant melanoma. Plast
Reconstr Surg 71(l):66–72, 1983
Elder DE, DuPont G IV, Van Horn M, Hurwitz S, Zehngebot L,
Goldman LI, LaRossa D, Hamilton R, Bondi E, Clark WH Jr: The
role of lymph node dissection for clinical stage I malignant
melanoma of intermediate thickness (1,51–3.99). Cancer
56:413–418, 1985
Cassileth BR, Clark WH Jr, Lusk EJ, Frederick BE, Thompson J,
Walsh WP: How well do physicians recognize melanoma and
other problem lesions? J Am Acad Dermatol 14:555–560, 1986
Cassileth BR, Lusk EJ, Guerry D VI, Clark WH Jr, Matozzo I,
Frederick BP: ‘‘Catalyst’’ symptoms in malignant melanoma.
J Gen Intern Med 2:1–4,1987
Cassileth BR, Temoshok L, Frederick BE, Walsh WP, Hurwitz
S, Guerry D, Clark WH, DiClemente RJ, Sweet DM, Blois MS,
Sagebiel RW: Patient and physician delay in melanoma
diagnosis. Am Acad Dermatol 18:591–598,1988
Clark WH Jr, Elder DE, DuPont G IV: The pathogenesis
and pathology of dysplastic nevi and malignant melanoma.
In: Farmer E, Hood A (ed). The Pathology of the Skin. Appleton-
Century-Crofts, New York, 1990
A book was published describing concepts of melanoma
biology and early notions about the significance of nevi in
melanoma risk and pathogenesis.
Clark WH Jr, Goldman LI, Mastrangelo MJ: Human Malignant
Melanoma. Grune and Stratton, New York, 1979, pp 1–509
Three educational videotapes were produced for families,
clinicians, and pathologists dealing with the subject of dysplastic
nevi in hereditary melanoma kindreds. These were widely
disseminated by the National Cancer Institute.
Elder DE, Clark WH Jr, Control and prevention of melanoma: a
program for melanoma-prone families. Videotape educational
program produced for Environmental Epidemiology Branch,
National Cancer Institute (30min), 1980
Elder DE, Clark WH Jr: Dysplastic nevi and melanoma: a
program for pathologists. Videotape educational program pro-
duced for Environmental Epidemiology Branch, National Cancer
Institute (30min), 1980
Elder DE, Clark WH Jr, Greene MH: Dysplastic nevi and
melanoma: a program for clinicians. Videotape produced for
Environmental Epidemiology Branch, National Cancer Institute
(57min), 1980
Dysplastic and Congenital Melanocytic Nevi Although melano-
cytic nevi are ubiquitous benign neoplasms of the skin, their
significance in tumor progression and in the pathogenesis of
melanoma was not recognized until recently, with Clark’s
investigations and teaching playing the major role in this
recognition. The first of these studies was influential in the
developing understanding of congenital nevi and their potential
role in melanoma pathogenesis.
Mark GJ, Mihm MC Jr, Liteplo MG, Reed RJ, Clark WH Jr:
Congenital melanocytic nevi of the small and garment type:
clinical, histological, and ultrastructural studies. Hum Pathol
4(3):295–418, 1973
With Mark Greene of the NCI, Clark first recognized the
significance of large, clinically atypical nevi as markers of
melanoma risk in members of hereditary melanoma-prone
kindreds, and in a series of classic papers the clinical and
histologic attributes of these lesions were defined.
Greene MH, Reimer RR, Clark WH Jr, Mastrangelo MJ:
Precursor lesions in familial melanoma. Semin Oncol 5(l):85–87,
1978
Reimer RR, Clark WH Jr, Greene MH, Ainsworth AM,
Fraumeni JF: Precursor lesions in familial melanoma. A new
genetic preneoplastic syndrome. JAMA 239(8):744–746, 1978
Clark WH Jr, Reimer RR, Greene M, Ainsworth AM,
Mastrangelo MJ: Origin of familial malignant melanoma from
heritable melanocytic lesions. the B-K Mole Syndrome. Arch
Dermatol 114:732–738, 1978
Greene MH, Clark WH Jr, Tucker MA, Elder DE, Kraemer KH,
Fraser MC, Guerry D IV, Witmer WK, Thompson J, Matozzo I:
Acquired precursors of cutaneous malignant melanoma: the familial
dysplastic nevus syndrome. N Engl J Med 312:91–97, 1985
Elder DE, Greene MH, Bondi EE, Clark WH Jr: Acquired
melanocytic nevi and melanoma: the dysplastic nevus syndrome.
In: Ackerman AB (ed.). Pathology of Malignant Melanoma, Vol. 1.
Masson Publishing USA Inc., New York, 1981, pp 185–215
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In later studies, the epidemiologic significance of dysplastic
nevi in melanoma-prone kindreds was elucidated.
Greene MH, Clark WH Jr, Tucker MA, Kraemer KH, Elder DE,
Fraser MC: High risk of malignant melanoma in melanoma-prone
families with the dysplastic nevi. Ann Intern Med 102:458–465, 1985
Kraemer KH, Tucker MA, Taron R, Elder DE, Clark WH Jr: Risk
of cutaneous melanoma in dysplastic nevus syndrome types A
and B (letter). N Engl J Med 315(25):1615–1616, 1986
Greene MH, Tucker MA, Clark WH Jr, Kraemer KH, Elder DE,
Fraser MC: Hereditary melanoma and the dysplastic nevus
syndrome: the risk of cancers other than melanoma. J Am Acad
Dermatol 16(4):792–797,1987
Kraemer KH, Greene MH, Tarone R, Elder D, Clark WH Jr,
Guerry DI V: Dysplastic naevi and cutaneous melanoma risk.
Lancet 11:1076–1077 1983
Greene MH, Clark WH Jr, Tucker MA, Elder DE, Kraemer KH,
Fraser MC, Bondi EE, Guerry D, Tuthill R, Hamilton R, La Rossa
D: Precursor naevi in cutaneous malignant melanoma: a
proposed nomenclature. Lancet 1024,1980
In the Pigmented Lesion Clinic, it was first recognized that
dysplastic nevi were commonly associated with sporadic as well
as hereditary melanoma.
Elder DE, Goldman LI, Goldman SC, Greene MJ, Clark WH Jr:
Dysplastic nevus syndrome: a phenotypic association of sporadic
cutaneous melanoma. Cancer 46(8):1787–1794, 1980
The role of dysplastic nevi as potential precursors of hereditary
melanoma was clearly recognized in the early papers and their
important role in sporadic melanoma was further defined in
studies from the Pigmented Lesion Group database.
Clark WH Jr, Elder DE, Guerry D IV, Epstein MN, Greene MH,
Van Horn M: A study of tumor progression: The precursor lesions
of superficial spreading and nodular melanoma. Hum Pathol
5(12):1147–1165, 1984
Collaborative studies with Greene and others ultimately led to
mapping of a melanoma susceptibility gene onto the short arm of
chromosome 1.
Greene MH, Goldin LR, Clark WH Jr, Lovrien E, Kraemer KH,
Tucker MA, Elder DE, Fraser MC, Rowe S: Familial cutaneous
malignant melanoma: autosomal dominant trait possibly linked to
the Rh locus. Proc Natl Acad Sci 80:6071–6075, 1980
Bale SJ, Dracopoli NC, Tucker MA, Clark WH Jr, Frazer MC,
Stanger BZ, Green P, Donis-Keller H, Housman DE, Greene MH:
Mapping the gene for hereditary cutaneous malignant melanoma-
dysplastic nevus to chromosome 1 p. NEngl J Med 310:1367–1372,
1988
Screening and surveillance of members of hereditary melano-
ma kindreds in the Pigmented Lesion Clinic has led to diagnosis
of melanomas at an earlier, more curable stage of their evolution.
Masri GD, Clark WH, Guerry DG, Halpern A, Thompson CJ,
Elder DE: Screening and surveillance of patients at high risk for
malignant melanoma results in detection of earlier disease. J Am
Acad Dermatol 22:1042–1048,1990
Biology of Melanoma In 1978, Clark with Koprowski and later
Herlyn of the Wistar Institute established and has since
maintained a productive long-term collaboration of basic and
clinical scientists. This collaboration resulted in the first produc-
tion of monoclonal antibodies to melanoma antigens, and to a
body of cell culture and cytogenetic work. Clark’s central
hypothesis of tumor progression from radial to vertical growth
phase in melanoma has provided an essential focus for these
studies. This interdisciplinary research would not have been
possible without the establishment of this complex cooperative
group of investigators at two institutions.
Melanoma-Associated Antigens Monoclonal antibodies have
been used to explore the antigenic phenotype of melanomas
and to search for therapeutically active agents.
Steplewski Z, Herlyn M, Herlyn D, Clark WH, Koprowski H:
Reactivity of monoclonal anti-melanoma anti-bodies with mela-
noma cells freshly isolated from primary and metastatic melano-
ma. Eur J Immunol 9:94–96, 1979
Herlyn M, Clark WH Jr, Mastrangelo MJ, DuPont GIV, Elder
DE, LaRossa D, Hamilton R, Bondi E, Tuthill R, Steplewski Z,
Koprowski H: Specific immunoreactivity of hybridoma-secreted
monoclonal anti-melanoma antibodies to culture cells and freshly
derived human cells. Cancer Res 40:3602–3609, 1980
Thompson JJ, Herlyn MF, Elder DE, Clark WH Jr, Steplewski Z,
Koprowski H: Expressions of DR antigens in human tumors.
Hybridoma 1(2):161–168, 1982
Thompson J, Herlyn MF, Elder DE, Clark WH Jr, Steplewski Z,
Koprowski H: Use of monoclonal antibodies in detection of
melanoma-associated antigens in intact human tumors. Am J
Pathol 107(3)357–361, 1982
Herlyn M, Steplewski Z, Herlyn D, Clark WH Jr, Ross AH,
Blaszczyk M, Pak KY, Koprowski H: Production and character-
ization of monoclonal antibodies against human malignant
melanoma. Cancer Invest 1(3):215–224,1983
Herlyn M, Herlyn D, Elder DE, Bondi E, LaRossa D, Hamilton
R, Sears HF, Balaban G, Guerry D IV, Clark WH, Koprowski H:
Phenotypic characteristics of cells derived from precursors of
human melanoma. Cancer Res 43:5502–5508, 1983
Atkinson B, Ernst CS, ClarkWH, Ghrist BFD, Ross AH, Herlyn M,
Herlyn D, Maul G, Steplewski Z, Koprowski H: Monoclonal
antibody to a highly glycosylated protein reacts in fixed tissue with
melanoma and other tumors. Hybridoma 4(3):243–255, 1985
Thurin J, Thurin M, Kimoto Y, Herlyn M, Lubeck MD, Elder
DE, Smerec-zynska M, Karlson K-A, Clark WH Jr, Steplewski Z,
Koprowski H: Monoclonal antibody-defined correlations in
melanoma between levels of GD2 and GD3 antigens and
antibody-mediated cytotoxicity. Cancer Res 47:1229–1233, 1987
Iliopoulos D, Ernst C, Steplewski Z, Jambrosic JA, Rodeck U,
Herlyn M, Clark WH Jr, Koprowski H, Herlyn D, Iliopoulos DC:
Inhibition of metastases of a human melanoma xenograft by
monoclonal antibody to the GD2/GD3 gangliosides. J Natl Cancer
Inst 81:440–444, 1989
Monoclonal antibodies have also been used to examine
mechanisms of tumor progression in melanoma.
Thurin J, Thurin M, Herlyn M, Elder DE, Steplewski Z, Clark
WH Jr, Koprowski H: GD2 ganglioside biosynthesis is a distinct
biochemical event in human melanoma tumor progression. Fed
Eur Biochem Soc 208(1):17–22, 1986
Elder DE, Ulrich R, Thurin J, Cardillo F, Clark WH, Stewart R:
Antigenic profile of tumor progression stages in human melano-
cytic nevi and melanomas. Cancer Res 49(18):5091–5096, 1989
Cytogenetics and Cell Biology Cytogenetic studies have explored
mechanisms of tumor progression in melanoma.
Balaban G, Herlyn M, Guerry D IV, Bartolo R, Koprowski H,
Clark WH, Nowell PC: Cytogenetics of human malignant
melanoma and premalignant lesions. Cancer Genet Cytogenet
11:429–439, 1984
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Balaban GB, Herlyn M, Clark WH Jr, Nowell PC: Karyotypic
evolution in human malignant melanoma. Cancer Genet Cyto-
genet 19:113–122, 1986
Parmiter AH, Balaban G, Clark WH Jr, Nowell PC: Possible
involvement of the chromosome region 10q24-26 in early
stages of melanocytic neoplasia. Cancer Genet Cytogenet
30:313–317, 1988
Parmiter AH, Balaban G, Herlyn M, Clark WH Jr, Nowell PC:
A t (1;19) translocation in three cases of human malignant
melanoma. Cancer Res 46:1526–1529,1986
Studies of growth characteristics of melanoma cells in culture
have confirmed that cells of the vertical growth phase have
biologic capacities similar to those of cells from metastases.
Herlyn M, Balaban G, Bennicelli J, Guerry D IV, Halaban R,
Herlyn D, Elder DE, Maul GG, Steplewski Z, Nowell PC, Clark
WH Jr, Koprowski H: Primary melanoma cells of the vertical
growth phase: Similarities to metastatic cells. J Natl Cancer Inst
74(2):283–289, 1988
Herlyn M, Turin J, Balaban G, Bennicelli JL, Herlyn D,
Elder DE, Bondi E, Guerry D, Nowell P, Clark WH, Koprowski H:
Characteristics of cultured human melanocytes isolated from
different stages of tumor progression. Cancer Res 45:5670–5676,
1985
Herlyn D, Elder DE, Bondi E, Atkinson B, Guerry D IV,
Koprowski H, Clark WH Jr: Human cutaneous nevi transplanted
to nude mice: a model for the study of the lesional steps in tumor
progression. Cancer Res 46:1339–1343,1986
Herlyn M, Clark WH, Rodeck U, Mancianti ML, Jambrosic J,
Koprowski H: Biology of disease: biology of tumor progression in
human melanocytes. Lab Invest 56(5):461–474, 1987
Mancianti ML, Herlyn M, Weil D, Jambrosic J, Rodeck U,
Bondi EE, Becker D, Diamond L, Clark WH, Koprowski H:
Growth and phenotypic characteristics of human nevus cells in
culture. J Invest Dermatol 90(2):134–141, 1987
Electron Microscopy of the Skin In 1958, Clark pioneered the use
of the newly developed tool of electron microscopy to begin a
series of studies of the skin and its constituent cells, publishing the
first description of the melanosome, the organelle that specifically
identifies the melanocyte, and in which melanin pigment is
synthesized.
Clark WH Jr, Hibbs RG (with the technical assistance of
Watson M): Electron microscope studies of the human epidermis:
the clear cell of Masson (dendritic cell or melanocyte). J Biophys
Biochem Cytol 4(6):679–684, 1958
Hibbs RG, Clark WH Jr (with the technical assistance of
Watson M): Electron microscope studies of the human epidermis:
the cell boundaries and topography of the stratum malpighii. J
Biophys Biochem Cytol 6(l):71–76, 1959
Clark WH Jr, Watson MC, Watson BEM: Two kinds of ‘‘clear’’
cells in the human epidermis with a report of a modified DOPA
reaction for electron microscopy. Pathol 39(3):333–344, 1961
Hori Y, Toda K, Pathak MA, Clark WH Jr, Fitzpatrick TB: A fine
structural study of the human epidermal melanosome complex and
its acid phospha-tase activity. J Ultrastruct Res 25:109–110, 1968
Leone P, Clark WH Jr: Ultrastructure of the intra-epidermal
melanocyte of the melanocytic nevus. Lab Invest 24:438, 1971
Clark WH Jr: Four types of cellular fine structure associated
with human amelanotic melanoma. Yale J Biol Med 46:428, 1972
Roth SI, Clark WH Jr: Ultrastructural evidence related to
the mechanism of keratin synthesis. In: Montagna W, Lobitz WC
Jr (ed.). The Epidermis. Academic Press, New York, 1964, pp
300–337
Clark WH, Bretton R: A comparative fine structural study of
melanogenesis in normal human epidermal melanocytes and in
certain human malignant melanoma cells. In: Helwig EB (ed.).
The Skin, International Academy of Pathology. The Williams &
Wilkins Co., Baltimore, MD, 1971, pp 197–214
Clark WH Jr, Heggeler BT, Bretton R: Electron microscope
observations of human cutaneous melanomas correlated with
their biologic behavior. Presented at The International Cancer
Conference, 1972, Sydney, Australia. In: Melanoma and Skin
Cancer. Sydney, Australia: VCN Blight, Government Printer, pp
121–141
Contributions to Diagnostic Dermatopathology Although a few
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